US Patent 10870699 Anti-CD47 antibodies and uses thereof
Patent 10870699 was granted and assigned to Celgene on December, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 28, 2015
0
Date of Patent
December 22, 2020
0
Patent Applicant
Patent Application Number
15541003
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10870699 Anti-CD47 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
